• Profile
Close

Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy – Results from the MRC OE02 oesophageal cancer trial

Histopathology Feb 28, 2018

Davarzani N, et al. - The prognostic value of tumor regression grade (TRG) with related pathologic factors in esophageal cancer (OC) patients enrolled in the Medical Research Council OE02 trial was determined. Independent of lymph node (LN) status, post-neoadjuvant chemotherapy (NAC) was shown to be the most significant prognostic factor. It was also determined that the potential clinical implications, such as adjuvant treatment or intensified follow-up, reinforced the importance of LN dissection for staging and prognostication.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay